Doing Business In Mexico

uk trade and investment logo ima logo
/media/124236/mexican_flag_re-size.jpg
 

Healthcare

Success Story

BioEden, the first company in the world to offer dental stem cells preservation, started business in Mexico in 2008. Sofar, BioEden Mexico has partnered with more that 500 renowned dentists and today stands as the market leader with operations in the entire country.In addition to offering dental stemcells preservation, BioEden Mexico is promoting research programs to find clinical and therapeutic applications for dental stem cells in various medical applications.

 

Key Fact

The medical device sector in Mexico
reached a US$3.58 billion value
in 2010 and it is expected to reach
a US$6.87 billion value by 2015.

Healthcare provision is a high priority for the current administration (2006- 2012). President Calderon's National Healthcare Programme concentrates on six main pillars: universal healthcare coverage; high care; reinforcement of infrastructure; prevention and promotion of health; a fair and adequate drug policy and an effective and dynamic health regulation.

Budget-wise, the healthcare sector is one of the sectors that has grown the most over the past years, representing 7 per cent of the GDP. In 2011, this sector was allocated the biggest budget in the history of Mexico.

In 2011, the federal budget authorised for the sector was US$11,506 million, with an annual growth rate of 15 per cent between 2006 and 2011.

In addition, the medical device sector in Mexico reached a US$3.58 billion value in 2010 and it is expected to reach a US$6.87 value by 2015.

Within the six pillars, President Calderon's priority is to achieve universal health coverage, by focusing on the following four areas:

  • In 2007 alone, over US$3.39 million was invested in expansion and modernisation.

  • A national promotion and prevention strategy.

  • Health Caravans, a plan that will provide medical services for the country's most isolated communities that lack sufficient medical infrastructure, mainly indigenous villages and communities.

  • Strategy for supplying medication at health institutions; US$324 million is now available to boost supplies at hospitals and units in the health sector.

UK/Mexico relations in the Healthcare sector are good and Mexico wishes to adopt the NHS model, focusing on the fundamental concepts of free at the point of delivery and universal coverage. Within the Healthcare sector the pharmaceutical and MedTech market have been the most dynamic, offering the most opportunities. This market accounts for approximately 1.21 per cent of the national GDP, generating US$11,376 million - a figure which is constantly increasing.

In October 18th, 2011, President Calderon announced the new Health Input Regulation Reform representing a significant opportunity for the pharmaceutical industry to develop new medicines and increase their market under the regulation of Federal Commission for Protection from Health Risks (COFEPRIS).


Business Opportunities

  • PPPs (Private and Public Partnerships).

  • Biomedical products.

  • Investment and supply of pharmaceuticals.

  • Medical equipment.

  • Healthcare promotion.

  • Training in PPP hospital management.

  • Training in geriatrics.

  • Consultancy and training for nurses.

  • Consultancy in institutional reform.

  • Quality assessment and management.

  • Accountability.

  • Telemedicine.

  • Medical informatics.

  • GP training in prescribing team building, management.

  • Primary healthcare and paramedics.

  • Patient safety.

     

Contact and Further Information

A report on the Mexican healthcare sector as well as more information about the specific business opportunities can be obtained by contacting the UKTI team in Mexico City: 
British Embassy Mexico City Tel: +52 55 1670 3243 Email: Marcela.Lopez@fco.gov.uk

 

Source - UKTI

 

Strategic Partners